Author: David Cooper
- Most recently observed institution: Pfizer Vaccine Research and Development, Pearl River, NY, USA
Rankings
- All-time downloads: 303,774 (rank: 83 )
- Categories:
- infectious diseases: 203,210 (rank: 74 (tie) )
- microbiology: 100,564 (rank: 136 (tie) )
Downloads per author, site-wide
Preprints
BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants
microbiology more details view paperNo download data for this paper yet.
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
infectious diseases more details view paper- Downloaded 72,890 times
- Download rankings, all-time:
- Site-wide: 79
- In infectious diseases: 29
- Year to date:
- Site-wide: 83
- Since beginning of last month:
- Site-wide: 192
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
infectious diseases more details view paper- Downloaded 70,201 times
- Download rankings, all-time:
- Site-wide: 84
- In infectious diseases: 33
- Year to date:
- Site-wide: 277
- Since beginning of last month:
- Site-wide: 1,807
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
microbiology more details view paper- Downloaded 58,333 times
- Download rankings, all-time:
- Site-wide: 104
- In microbiology: 8
- Year to date:
- Site-wide: 17
- Since beginning of last month:
- Site-wide: None
Neutralization of spike 69/70 deletion, E484K, and N501Y SARS-CoV-2 by BNT162b2 vaccine-elicited sera
microbiology more details view paper- Downloaded 42,231 times
- Download rankings, all-time:
- Site-wide: 159
- In microbiology: 13
- Year to date:
- Site-wide: 30
- Since beginning of last month:
- Site-wide: 2,733
Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine
infectious diseases more details view paper- Downloaded 23,625 times
- Download rankings, all-time:
- Site-wide: 329
- In infectious diseases: 122
- Year to date:
- Site-wide: 669
- Since beginning of last month:
- Site-wide: 8,486
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
infectious diseases more details view paper- Downloaded 21,177 times
- Download rankings, all-time:
- Site-wide: 370
- In infectious diseases: 138
- Year to date:
- Site-wide: 77
- Since beginning of last month:
- Site-wide: 11
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
infectious diseases more details view paper- Downloaded 15,317 times
- Download rankings, all-time:
- Site-wide: 532
- In infectious diseases: 190
- Year to date:
- Site-wide: 165
- Since beginning of last month:
- Site-wide: 2,167
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!